A study led by Dr. Roland Staud, an associate professor of medicine at the University of Florida in Gainesville, found that a common ingredient in cough syrup may be the next new hope in controlling pain of fibromyalgia patients. The cough suppressant, dextromethorphan, helped relieve pain by blocking a chemical messenger (NIMDA) from sending the brain pain signals.
More than thirty percent of people who survive a stroke on the left side of their brain wind up with speech impairments. A recent study reported in the June, 2005 issue of the American Heart Association's Stroke magazine found that short term speech therapy for these stroke patients can be more effective than therapy spread out over the course of a year (the normal time for such treatment).